A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning

Am J Surg. 1998 Dec;176(6):497-501. doi: 10.1016/s0002-9610(98)00250-5.

Abstract

Background: We reviewed our image-guided core needle breast biopsy (IGCNBB) experience with patients diagnosed with invasive carcinoma (IC) to determine the accuracy of a core biopsy diagnosis of invasion and our ability to perform a single definitive cancer operation.

Methods: All IGCNBBs between July 1993 and July 1997 were reviewed to identify patients diagnosed with IC. Data included initial surgical treatment, surgical pathology, and subsequent surgical treatment.

Results: Of the 1,676 biopsies, invasive carcinoma was diagnosed in 208 with follow-up in 204 cases. Invasive carcinoma diagnosis was confirmed in 202 of 204 cases (99%). One hundred ninety-two patients had surgical treatment. Of these 192 patients, 173 (90%) could have achieved definitive surgical treatment with a single operation.

Conclusions: An IGCNBB diagnosis of IC is accurate and allows for definitive breast cancer therapy. The potential impact on patient management is that a single operation can usually accomplish what traditionally has required at least two surgical procedures.

MeSH terms

  • Biopsy / methods
  • Breast / pathology*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / pathology
  • Breast Neoplasms / surgery*
  • Carcinoma, Ductal, Breast / diagnosis
  • Carcinoma, Ductal, Breast / pathology
  • Carcinoma, Ductal, Breast / surgery*
  • Female
  • Humans
  • Mastectomy
  • Mastectomy, Segmental
  • Neoplasm Invasiveness
  • Patient Care Planning
  • Retrospective Studies
  • Time Factors
  • Ultrasonography